Sign in

    Craig JonesStifel, Nicolaus & Company

    Craig Jones's questions to Astrana Health Inc (ASTH) leadership

    Craig Jones's questions to Astrana Health Inc (ASTH) leadership • Q2 2025

    Question

    Craig Jones questioned the trend in Medicaid rates for 2025, referencing the previous year's mismatch between rates and cost trends, and asked about the expected timeline for restoring Medicaid margins to their target levels.

    Answer

    President & CEO Brandon Sim explained that the Medicaid environment remains volatile and that while a rate update has not yet occurred in California, they are in active negotiations with payers to address the rate-acuity mismatch. He noted that a conservative view is already baked into guidance and the 2027 outlook.

    Ask Fintool Equity Research AI

    Craig Jones's questions to Astrana Health Inc (ASTH) leadership • Q2 2025

    Question

    Craig Jones questioned the trend in Medicaid rates during 2025, referencing the previous year's mismatch between rates and cost trends, and asked for a timeline on when the Medicaid book of business is expected to return to its target margin profile.

    Answer

    President & CEO Brandon Sim acknowledged the volatility in the Medicaid environment and noted that California has not yet issued a rate update. He explained that Astrana is in active negotiations with payers to resolve the rate-acuity mismatch but has not factored any positive resolution into its guidance or its 2027 financial bridge, indicating a conservative outlook has been baked in.

    Ask Fintool Equity Research AI

    Craig Jones's questions to Privia Health Group Inc (PRVA) leadership

    Craig Jones's questions to Privia Health Group Inc (PRVA) leadership • Q2 2025

    Question

    Craig Jones from Bank of America asked for guideposts on how much Privia's platform can improve a partner's margins, both quickly upon implementation and over the longer term.

    Answer

    CEO Parth Mehrotra outlined a multi-layered value proposition that grows over time. Initially, partners see expense savings and immediate revenue lift from enhanced payer contracts. This is followed by a 10-20% productivity lift as physicians are freed from administrative tasks. Over time, value is compounded through participation in value-based care programs with increasing levels of shared savings. He cited past case studies where practices have doubled their top and bottom lines over 7-10 years with Privia, an unmatched value proposition that drives high retention.

    Ask Fintool Equity Research AI

    Craig Jones's questions to Privia Health Group Inc (PRVA) leadership • Q4 2024

    Question

    Craig Jones asked about the normalized free cash flow conversion rate in a future state, assuming a full cash tax rate and no significant working capital adjustments.

    Answer

    CFO David Mountcastle estimated that the normalized conversion rate would likely settle in the 70% to 80% range. He noted it would be close to the current 80% guidance but could be slightly lower once the company's NOLs are fully utilized and assuming neutral working capital.

    Ask Fintool Equity Research AI

    Craig Jones's questions to Oscar Health Inc (OSCR) leadership

    Craig Jones's questions to Oscar Health Inc (OSCR) leadership • Q2 2025

    Question

    Craig Jones of Bank of America asked where Oscar's requested 2026 rate increases are positioned relative to competitors in each state and sought clarification on the magnitude of the "double-digit" rate increases mentioned.

    Answer

    CFO Scott Blackley explained that Oscar's pricing is built from the ground up to cover all known risks, resulting in significant double-digit increases. He stated that on average, their price changes will be comparable to larger peers. He confirmed "double-digit" means 10% or more and that the increases would be "multiple times" what was seen in the prior year.

    Ask Fintool Equity Research AI

    Craig Jones's questions to agilon health inc (AGL) leadership

    Craig Jones's questions to agilon health inc (AGL) leadership • Q2 2025

    Question

    Craig Jones from Bank of America followed up on quality incentives, asking about the potential margin opportunity if these incentives were implemented across 100% of agilon's membership.

    Answer

    CFO Jeff Schwaneke clarified that such programs are already present in the majority of contracts. The significant change, he noted, is that the dollar value of these incentives is escalating as payers place a higher premium on quality performance, which benefits agilon's model.

    Ask Fintool Equity Research AI

    Craig Jones's questions to Alignment Healthcare Inc (ALHC) leadership

    Craig Jones's questions to Alignment Healthcare Inc (ALHC) leadership • Q2 2025

    Question

    Craig Jones of Bank of America inquired about the yield on marketing dollars and customer acquisition costs, particularly whether Alignment has seen increased efficiency as competitors pull back on benefits.

    Answer

    CEO John Kao confirmed that they have seen a higher yield on marketing dollars but declined to quantify it ahead of the Annual Enrollment Period (AEP). He attributed much of the company's growth to word-of-mouth and strong broker partnerships focused on quality. Kao suggested that as the company scales, there is a future opportunity to invest more in brand development to accelerate growth further.

    Ask Fintool Equity Research AI

    Craig Jones's questions to Alignment Healthcare Inc (ALHC) leadership • Q3 2024

    Question

    Craig Jones asked about the expected magnitude of MBR improvement as the large cohort of new 2024 members matures into its second year in 2025.

    Answer

    Executive Robert Freeman stated that historically, Alignment sees approximately 300 basis points of MBR improvement as members transition from their first to their second year. He highlighted this as a significant, multi-year embedded profit opportunity, underscoring the importance of the company's strong member retention.

    Ask Fintool Equity Research AI